MANUEL
PEREZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biogipuzkoa (3)
2021
-
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
Molecular Therapy - Nucleic Acids, Vol. 26, pp. 174-191
2016
-
Six serum miRNAs fail to validate as myotonic dystrophy type 1 biomarkers
PLoS ONE, Vol. 11, Núm. 2
2013
-
Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients
Human Molecular Genetics, Vol. 22, Núm. 4, pp. 704-716